Total Payments
$3,357
2024 Payments
$248.43
Companies
17
Transactions
93
Medicare Patients
6,075
Medicare Billing
$377,387
Payment Breakdown by Category
Food & Beverage$3,357 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,357 | 93 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $846.37 | 18 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $462.23 | 8 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $402.29 | 9 | $0 (2018) |
| Novo Nordisk Inc | $391.80 | 8 | $0 (2024) |
| Amgen Inc. | $320.20 | 9 | $0 (2024) |
| Radius Health, Inc. | $176.43 | 7 | $0 (2019) |
| Lilly USA, LLC | $165.56 | 6 | $0 (2021) |
| Bayer Healthcare Pharmaceuticals Inc. | $150.19 | 9 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $130.65 | 2 | $0 (2019) |
| Biogen, Inc. | $101.66 | 6 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $248.43 | 12 | Novartis Pharmaceuticals Corporation ($72.60) |
| 2023 | $306.56 | 8 | Amgen Inc. ($114.17) |
| 2022 | $236.52 | 9 | Bayer HealthCare Pharmaceuticals Inc. ($79.61) |
| 2021 | $348.06 | 15 | Janssen Pharmaceuticals, Inc ($144.37) |
| 2020 | $196.49 | 6 | Janssen Pharmaceuticals, Inc ($165.56) |
| 2019 | $907.20 | 15 | Janssen Pharmaceuticals, Inc ($339.87) |
| 2018 | $642.24 | 13 | AstraZeneca Pharmaceuticals LP ($172.07) |
| 2017 | $471.33 | 15 | Sunovion Pharmaceuticals Inc. ($278.13) |
All Payment Transactions
93 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/24/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $25.94 | General |
| Category: PSYCHIATRY | ||||||
| 09/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: Diabetes | ||||||
| 09/06/2024 | Boston Scientific Corporation | Vercise (Device) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: Vercise_NMD | ||||||
| 07/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: Diabetes | ||||||
| 06/05/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Bone Health | ||||||
| 05/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Cardio-renal | ||||||
| 04/10/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $28.25 | General |
| Category: Bone Health | ||||||
| 01/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/03/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: VACCINES | ||||||
| 11/01/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/26/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Cardio-renal | ||||||
| 07/19/2023 | SANOFI PASTEUR INC. | FLUZONE HIGH-DOSE (Biological), FLUZONE QUADRIVALENT NORTHERN HEMISPHERE, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Vaccines | ||||||
| 03/22/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $40.09 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/23/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Cardio-renal | ||||||
| 02/22/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $59.26 | General |
| Category: Respiratory | ||||||
| 02/08/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $114.17 | General |
| Category: Cardiology | ||||||
| 01/11/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Cardio-renal | ||||||
| 11/22/2022 | Corium, LLC | ADLARITY (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Treatment of dementia of the Alzheimers type | ||||||
| 10/26/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Cardio-renal | ||||||
| 07/28/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Cardio-renal | ||||||
| 05/18/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Cardio-renal | ||||||
| 04/27/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 95 | 105 | $16,737 | $4,403 |
| 2022 | 13 | 1,367 | 1,607 | $154,878 | $87,077 |
| 2021 | 22 | 1,741 | 2,228 | $216,749 | $127,113 |
| 2020 | 21 | 2,872 | 3,474 | $282,806 | $158,795 |
Total Patients
6,075
Total Services
7,414
Medicare Billing
$377,387
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 63 | 70 | $12,373 | $3,347 | 27.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 35 | $4,363 | $1,056 | 24.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 467 | 474 | $49,704 | $32,475 | 65.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 139 | 245 | $44,501 | $21,800 | 49.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 493 | 502 | $20,745 | $13,603 | 65.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 81 | 109 | $14,029 | $6,672 | 47.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 19 | 24 | $9,467 | $5,061 | 53.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 27 | 29 | $7,425 | $3,883 | 52.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 19 | 64 | $2,049 | $1,034 | 50.5% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2022 | 16 | 30 | $1,707 | $797.86 | 46.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 16 | 18 | $1,334 | $681.11 | 51.0% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 28 | 28 | $900.86 | $589.40 | 65.4% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 19 | 26 | $367.38 | $181.25 | 49.3% |
| 82947 | Blood glucose (sugar) level | Office | 2022 | 32 | 46 | $2,408 | $179.50 | 7.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 11 | 12 | $240.72 | $118.80 | 49.4% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 508 | 508 | $49,767 | $33,148 | 66.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 167 | 315 | $53,468 | $27,915 | 52.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 122 | 205 | $24,428 | $12,265 | 50.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 29 | 196 | $18,302 | $10,927 | 59.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 548 | 548 | $12,957 | $8,620 | 66.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 48 | 48 | $10,624 | $7,754 | 73.0% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 25 | 25 | $9,149 | $5,332 | 58.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 21 | 21 | $6,098 | $3,590 | 58.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 18 | 21 | $5,472 | $3,261 | 59.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 13 | 32 | $4,276 | $2,564 | 60.0% |
About Dr. Jerry Jarrell, MD
Dr. Jerry Jarrell, MD is a Internal Medicine healthcare provider based in Bartlesville, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1194717975.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jerry Jarrell, MD has received a total of $3,357 in payments from pharmaceutical and medical device companies, with $248.43 received in 2024. These payments were reported across 93 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($3,357).
As a Medicare-enrolled provider, Jarrell has provided services to 6,075 Medicare beneficiaries, totaling 7,414 services with total Medicare billing of $377,387. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Bartlesville, OK
- Active Since 08/18/2005
- Last Updated 04/05/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1194717975
Products in Payments
- XARELTO (Drug) $568.36
- FARXIGA (Drug) $368.27
- INVOKANA (Drug) $278.01
- Ozempic (Drug) $277.92
- UTIBRON (Drug) $263.19
- Repatha (Biological) $230.33
- Tymlos (Biological) $176.43
- Kerendia (Drug) $150.19
- JARDIANCE (Drug) $130.65
- LONHALA MAGNAIR (Drug) $124.16
- LEQVIO (Drug) $92.47
- ADUHELM (Biological) $73.85
- BREZTRI (Drug) $59.26
- RYBELSUS (Drug) $57.29
- Rybelsus (Drug) $56.59
- TRULICITY (Drug) $53.91
- EVENITY (Biological) $44.45
- FORTEO (Drug) $36.46
- BYDUREON (Drug) $34.70
- EMGALITY (Drug) $34.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bartlesville
Megan Barber, D.o, D.O
Internal Medicine — Payments: $17,791
Internal Medicine $17,791
Dr. Todd Thomas, D.o, D.O
Internal Medicine — Payments: $9,134
Internal Medicine $9,134
Sharron Blaylock, M.d, M.D
Internal Medicine — Payments: $3,367
Internal Medicine $3,367
Zeyfoula Beytoula, Md, MD
Internal Medicine — Payments: $151.97
Internal Medicine $151.97
Samuel Brown, Md, MD
Internal Medicine — Payments: $88.77
Internal Medicine $88.77
Dr. Gerald Reed, D.o, D.O
Internal Medicine — Payments: $85.61
Internal Medicine $85.61